SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Oncothyreon
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jibacoa who wrote (1621)4/6/2001 8:33:28 AM
From: Ian@SI  Read Replies (2) of 2344
 
Bernard,

I suspect that the BusinessWeek story was done a while ago. Didn't BIOM say it closed off enrollment with more than 1000 patients?

Biomira has enrolled 903 patients for its Phase III clinical trial ...

Wilder,

In your earlier note, the comment that one could always buy in 30 points higher if the Ph III produces good results.

Were you really serious about a $30 bump to a $6 stock just on news? How large is the Metastatic Breast cancer population? I'd be overjoyed with half that bump on good news.

Ian.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News